Latest data from May 6, 2022
Number of Health Center respondents = 23 (64% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
Metrics |
Value |
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 |
977 |
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) |
69.43% |
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 |
53 |
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) |
73.33% |
Patients by Race and Ethnicity
Race/Ethnicity |
Patients Tested, Virus Detection (PCR, Antigen)2 |
Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
White, Non-Hispanic/Latino Patients |
27.12% |
22.64% |
White, Hispanic/Latino Patients |
6.45% |
16.98% |
Black/African American, Non-Hispanic/Latino Patients |
48.72% |
37.74% |
Black/African American, Hispanic/Latino Patients |
0.92% |
1.89% |
Asian Patients3 |
0.72% |
0.00% |
American Indian/Alaska Native Patients3 |
1.64% |
0.00% |
Native Hawaiian/Other Pacific Islander Patients3 |
0.31% |
0.00% |
Patients with More Than One Race3 |
1.74% |
0.00% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
1.13% |
5.66% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
0.92% |
0.00% |
Unreported/Refused to Report Race and Ethnicity |
10.34% |
15.09% |
Patients Vaccinated
Metrics |
Value |
COVID-19 Immunization Series Initiated |
196 |
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization |
78.34% |
COVID-19 Immunization Series Completed |
265 |
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization |
67.21% |
COVID-19 Immunization Series Additional |
903 |
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine |
83.52% |
Vaccinations by Race and Ethnicity
Race/Ethnicity |
Patient COVID-19 Immunization Series Initiated2 |
Patient COVID-19 Immunization Series Completed2 |
Patient COVID-19 Immunization Series Additional2 |
White, Non-Hispanic/Latino Patients |
17.35% |
30.19% |
15.06% |
White, Hispanic/Latino Patients |
5.61% |
6.79% |
1.33% |
Black/African American, Non-Hispanic/Latino Patients |
49.49% |
43.77% |
43.74% |
Black/African American, Hispanic/Latino Patients |
0.00% |
0.38% |
1.11% |
Asian Patients3 |
0.00% |
0.38% |
0.78% |
American Indian/Alaska Native Patients3 |
0.00% |
2.26% |
27.46% |
Native Hawaiian/Other Pacific Islander Patients3 |
1.02% |
0.00% |
0.11% |
Patients with More Than One Race3 |
1.53% |
1.89% |
0.55% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
5.10% |
6.42% |
1.22% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
2.55% |
0.75% |
0.78% |
Unreported/Refused to Report Race and Ethnicity |
17.35% |
7.17% |
7.86% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
Metrics |
Value |
Less Than 1 Hour |
39.13% |
1 to 24 Hours |
21.74% |
More Than 24 Hours |
34.78% |
N/A |
4.35% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
Metrics |
Value |
Financial reimbursement for costs associated with vaccine administration |
4.35% |
Staffing to administer the vaccine |
39.13% |
Vaccine confidence |
21.74% |
Vaccine storage capacity |
4.35% |
Vaccine supply |
4.35% |
Other |
17.39% |
None |
34.78% |
Operations and Staff
Metrics |
Value |
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program |
17.39% |
Average Percent of Health Center Visits Conducted Virtually |
13.26% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
Metrics |
Value |
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics |
39.13% |
Number of Mobile Van Sites |
6 |
Number of Pop-up Clinics |
8 |
Number of School-Based Vaccination Sites |
1 |
Number of Family Vaccination Clinics |
7 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
Metrics |
Value |
Direct provision of monoclonal antibody therapies |
13.04% |
Refer patients to another organization that provides monoclonal antibody therapies |
52.17% |
None |
34.78% |
Challenges in Providing Access to Monoclonal Antibody Therapy
Metrics |
Value |
Access to therapeutics |
8.70% |
Patient awareness/education |
4.35% |
Staffing capacity |
30.43% |
Therapy administration/onsite logistics |
21.74% |
Other |
0.00% |
None |
65.22% |
Test Kit Distribution
Metrics |
Value |
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program |
6 |
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program |
969 |
Test Kit Distribution Methods4
Metrics |
Value |
Provided to Existing Health Center Patients |
83.33% |
Provided to General Public Who Came to the Health Center |
83.33% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) |
0.00% |
Provided at Other Community Events |
33.33% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals |
0.00% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals |
33.33% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals |
33.33% |
Provided to school-age children and/or their families directly or through partnerships with schools |
0.00% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities |
16.67% |
Other |
0.00% |
N95 Mask Distribution
Metrics |
Value |
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program |
8 |
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program |
6,713 |
N95 Mask Distribution Methods5
Metrics |
Value |
Provided to Existing Health Center Patients |
75.00% |
Provided to General Public Who Came to the Health Center |
62.50% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) |
12.50% |
Provided at Other Community Events |
50.00% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals |
0.00% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals |
0.00% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals |
12.50% |
Provided to school-age children and/or their families directly or through partnerships with schools |
0.00% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities |
12.50% |
Other |
0.00% |
Oral Antiviral Medication Distribution
Metrics |
Value |
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program |
2 |
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication |
0.00% |
Oral Antiviral Medication Distribution by Race and Ethnicity
Race/Ethnicity |
Value |
White, Non-Hispanic/Latino Patients |
100.00% |
White, Hispanic/Latino Patients |
0.00%
|
Black/African American, Non-Hispanic/Latino Patients |
0.00%
|
Black/African American, Hispanic/Latino Patients |
0.00% |
Asian Patients3 |
0.00% |
American Indian/Alaska Native Patients3 |
0.00% |
Native Hawaiian/Other Pacific Islander Patients3 |
0.00% |
Patients with More Than One Race3 |
0.00%
|
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
0.00% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
0.00% |
Unreported/Refused to Report Race and Ethnicity |
0.00% |
Oral Antiviral Medication Distribution by Population Type
Metrics |
Value |
Migratory/Agricultural Workers |
0.00% |
Patients Experiencing Homelessness |
0.00% |
Patients Who Are Residents of Public Housing |
0.00% |
Patients with Limited English Proficiency |
0.00% |
Children Under 18 Years of Age |
0.00% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.